ATRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Atara Biotherapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$8.96−0.22 (-2.40%)
Close on Oct 19, 2026
- Market cap
- $134.70M
- P/E (TTM)
- 3.5
- Dividend yield
- –
Dividends
Atara Biotherapeutics has not reported a dividend
No dividend per share appears in Atara Biotherapeutics's annual filings since fiscal 2012.